Skip to main content

2023 | OriginalPaper | Buchkapitel

5. Symptomkontrolle

verfasst von : Herbert Watzke

Erschienen in: Palliativmedizin

Verlag: Springer Berlin Heidelberg

Zusammenfassung

Neben Schmerzen können Palliativpatienten unter einer Reihe anderer, ebenso belastender Beschwerden leiden, zu denen auch die Atemnot zählt. Atemnot ist zuerst ein subjektives Gefühl, dessen Schwere somit nur Patienten selbst beurteilen können. Eine sorgfältige Ursachensuche ist angezeigt. Ebenso können Übelkeit und Erbrechen verschiedene Ursachen haben, die etwa im Verdauungstrakt selbst liegen oder durch Stoffwechselentgleisungen ausgelöst werden, durch cerebrale Veränderungen hervorgerufen werden, oder nicht selten einfach als Nebenwirkungen von Medikamenten entstehen. Ein häufiges Problem stellt die intestinale Obstipation und/oder Obstruktion dar, zu deren Behandlung individuell angepasste Behandlungskonzepte existieren. Intestinale Obstruktion und Hyperkalzämie können zu einer schweren Symptomlast führen, die differenziert anzugehen ist. Häufig und sehr belastend für Patienten, Angehörige und Betreuungsteam ist das terminale Delir, für dessen Behandlung mehrere Medikamente zur Verfügung stehen.
Literatur
Zurück zum Zitat Adams L, Chronos N, Lane G, Guz A (1985) The measurement of breathlessness induced in normal subjects: validity of two scaling techniques. Clin Sci (Lond) 69:7–16PubMedCrossRef Adams L, Chronos N, Lane G, Guz A (1985) The measurement of breathlessness induced in normal subjects: validity of two scaling techniques. Clin Sci (Lond) 69:7–16PubMedCrossRef
Zurück zum Zitat Akechi T, UchitomiY OH (1996) Usage of haloperidol for delirium in cancer patients. Support Cancer Care 4:390–392CrossRef Akechi T, UchitomiY OH (1996) Usage of haloperidol for delirium in cancer patients. Support Cancer Care 4:390–392CrossRef
Zurück zum Zitat Allard P, Lamontagne C, Bernard P, Trenblay C (1999) How effective are supplementary doses of opioids for dyspnea in terminally ill cancer patients. J Pain Symptom Manage 17:256–265PubMedCrossRef Allard P, Lamontagne C, Bernard P, Trenblay C (1999) How effective are supplementary doses of opioids for dyspnea in terminally ill cancer patients. J Pain Symptom Manage 17:256–265PubMedCrossRef
Zurück zum Zitat Alt-Epping B, Sitte T, Nauck F, Radbruch L (2010) Sedierung in der Palliativmedizin. Z Palliativmed 11:112–122CrossRef Alt-Epping B, Sitte T, Nauck F, Radbruch L (2010) Sedierung in der Palliativmedizin. Z Palliativmed 11:112–122CrossRef
Zurück zum Zitat American Psychiatric Association (1994) Diagnostic and statistical Manual of Mental disorders. APA, Washington DC American Psychiatric Association (1994) Diagnostic and statistical Manual of Mental disorders. APA, Washington DC
Zurück zum Zitat Anti M, Pignataro G, Armuzzi A et al (1998) Water supplementation enhances the effect of high fiber diet on stool frequency and laxative consumption in adult patients with functional constipation. Hepatogastroenterology 45:727PubMed Anti M, Pignataro G, Armuzzi A et al (1998) Water supplementation enhances the effect of high fiber diet on stool frequency and laxative consumption in adult patients with functional constipation. Hepatogastroenterology 45:727PubMed
Zurück zum Zitat AWMF (2013) S2k-Leitlinie Chronische Obstipation, aktueller Stand: 02/2013. Register-Nr. 021/019 AWMF (2013) S2k-Leitlinie Chronische Obstipation, aktueller Stand: 02/2013. Register-Nr. 021/019
Zurück zum Zitat AWMF (2015) S3-Leitlinie Palliativmedizin für Patienten mit einer nicht heilbaren Krebserkrankung, Version 1.0 – Mai 2015. Register-Nr: 128/001OL AWMF (2015) S3-Leitlinie Palliativmedizin für Patienten mit einer nicht heilbaren Krebserkrankung, Version 1.0 – Mai 2015. Register-Nr: 128/001OL
Zurück zum Zitat Body JJ, Bartl R, Bruckhardt P et al (1998) Current use of bisphosphonates in oncology. J Clin Oncol 16(12):3890–3899PubMedCrossRef Body JJ, Bartl R, Bruckhardt P et al (1998) Current use of bisphosphonates in oncology. J Clin Oncol 16(12):3890–3899PubMedCrossRef
Zurück zum Zitat Breitbart W, Marotty R, Platt M (1996) A double-blind comparison trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry 153:231–237PubMedCrossRef Breitbart W, Marotty R, Platt M (1996) A double-blind comparison trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry 153:231–237PubMedCrossRef
Zurück zum Zitat Breitbart W (2001) Diagnosis and management of delirium in the terminally ill. In: Portenoy, BE (Hrsg) Topics in Palliative care, Vol 5. Oxford University Press, New York, S 303–321 Breitbart W (2001) Diagnosis and management of delirium in the terminally ill. In: Portenoy, BE (Hrsg) Topics in Palliative care, Vol 5. Oxford University Press, New York, S 303–321
Zurück zum Zitat Bruera E, Fainsinger R, Miller M, Kuehn N (1992) The assessment of pain intensity in patients with cognitive failure. J Pain Symp Man 7(5):267–270CrossRef Bruera E, Fainsinger R, Miller M, Kuehn N (1992) The assessment of pain intensity in patients with cognitive failure. J Pain Symp Man 7(5):267–270CrossRef
Zurück zum Zitat Bruera E, Hui D, Dalal S, Torres-Vigil I et al (2013) Parenteral hydration in patients with advanced cancer: a multicenter, double-blind, placebo-controlled randomized trial. J Clin Oncol 31(1):111–118PubMedCrossRef Bruera E, Hui D, Dalal S, Torres-Vigil I et al (2013) Parenteral hydration in patients with advanced cancer: a multicenter, double-blind, placebo-controlled randomized trial. J Clin Oncol 31(1):111–118PubMedCrossRef
Zurück zum Zitat Chua TP, Harrington D, Ponikowski P et al (1997) Effects of dihydrocodein on chemosensitivity and exercise tolerance in patients with chronic heart failure. J Am Coll Cardiol 29:147–152PubMedCrossRef Chua TP, Harrington D, Ponikowski P et al (1997) Effects of dihydrocodein on chemosensitivity and exercise tolerance in patients with chronic heart failure. J Am Coll Cardiol 29:147–152PubMedCrossRef
Zurück zum Zitat Currow DC, Coughlan M, Fardell B, Cooney NJ (1997) Use of ondasentron in palliative medicine. J Pain Symptom Manage 13:302–307PubMedCrossRef Currow DC, Coughlan M, Fardell B, Cooney NJ (1997) Use of ondasentron in palliative medicine. J Pain Symptom Manage 13:302–307PubMedCrossRef
Zurück zum Zitat Currow DC, Quinn S, Agar M et al (2015) Double-blind, placebo-controlled, randomized trial of octreotide in malignant bowel obstruction. J Pain Symptom Manage 49(5):814–821PubMedCrossRef Currow DC, Quinn S, Agar M et al (2015) Double-blind, placebo-controlled, randomized trial of octreotide in malignant bowel obstruction. J Pain Symptom Manage 49(5):814–821PubMedCrossRef
Zurück zum Zitat Drossman DA (2006) Rome III: The functional gastrointestinal disorders, 3. Aufl. Degnon Associates Inc, McLean, VA Drossman DA (2006) Rome III: The functional gastrointestinal disorders, 3. Aufl. Degnon Associates Inc, McLean, VA
Zurück zum Zitat Drossman et al (1990) Identificationof subgroups of functiomal gastrointestinal disorders. Gatroenterol Int 3:159–172 Drossman et al (1990) Identificationof subgroups of functiomal gastrointestinal disorders. Gatroenterol Int 3:159–172
Zurück zum Zitat Emanuel EJ, Fairclough DL, Slutsman J, Emanuel LL (2000) Understanding economic and other burdens of terminal illness: experience of patients and their caregivers. Ann Intern Med 132:451–459PubMedCrossRef Emanuel EJ, Fairclough DL, Slutsman J, Emanuel LL (2000) Understanding economic and other burdens of terminal illness: experience of patients and their caregivers. Ann Intern Med 132:451–459PubMedCrossRef
Zurück zum Zitat Evans KC, Bahnzett RB, Adams L (2002) BOLD fMRI identifies limbic, paralimbic, and cerebellar activation during air hunger. J Neurophysiol 88:1500–1511PubMedCrossRef Evans KC, Bahnzett RB, Adams L (2002) BOLD fMRI identifies limbic, paralimbic, and cerebellar activation during air hunger. J Neurophysiol 88:1500–1511PubMedCrossRef
Zurück zum Zitat Fainsinger R, McEachern T, Hanson J (1991) Symptome control during the last week of life in a palliative care unit. J Palliative Care 7:5–11 Fainsinger R, McEachern T, Hanson J (1991) Symptome control during the last week of life in a palliative care unit. J Palliative Care 7:5–11
Zurück zum Zitat Fallon B (1998) Nausea and vomiting unrelated to case treatment. In: Berger AM, Portenoy RK, Weissman DE (Hrsg) Principle and practice of supportive oncology. Lippincott Williams and Wilkins, Philadelphia, S 179–190 Fallon B (1998) Nausea and vomiting unrelated to case treatment. In: Berger AM, Portenoy RK, Weissman DE (Hrsg) Principle and practice of supportive oncology. Lippincott Williams and Wilkins, Philadelphia, S 179–190
Zurück zum Zitat Fernandez F, Levy J, Mansell P (1989) Management of delirium in terminally ill AIDS patients. Int J Psychiat Med 19:165–172CrossRef Fernandez F, Levy J, Mansell P (1989) Management of delirium in terminally ill AIDS patients. Int J Psychiat Med 19:165–172CrossRef
Zurück zum Zitat Feuer DJ, Broadley KE (1999) Systematic review of corticosteroids for the resolution of malignant bowel obstruction in advanced gynaecological and gastrointestinal cancers. Ann Oncol 10:1035–1040PubMedCrossRef Feuer DJ, Broadley KE (1999) Systematic review of corticosteroids for the resolution of malignant bowel obstruction in advanced gynaecological and gastrointestinal cancers. Ann Oncol 10:1035–1040PubMedCrossRef
Zurück zum Zitat Gaginella TS, Bris P (1978) Laxatives: an update on the mechanism of action. Life Sci 23:1001–1010PubMedCrossRef Gaginella TS, Bris P (1978) Laxatives: an update on the mechanism of action. Life Sci 23:1001–1010PubMedCrossRef
Zurück zum Zitat George J, Crawford D, Lewis T et al (1990) Percutaneous endoscopic gastrostomy: a tow year experience. Med J Aust 152:17–20PubMedCrossRef George J, Crawford D, Lewis T et al (1990) Percutaneous endoscopic gastrostomy: a tow year experience. Med J Aust 152:17–20PubMedCrossRef
Zurück zum Zitat Glare P, Peirera G, Krsitjanson LJ et al (2001) Systematic review of the efficacy of antiemetic in the treatment of nausea in patients with far-advanced cancer. Support Care Cancer 12:432–440CrossRef Glare P, Peirera G, Krsitjanson LJ et al (2001) Systematic review of the efficacy of antiemetic in the treatment of nausea in patients with far-advanced cancer. Support Care Cancer 12:432–440CrossRef
Zurück zum Zitat Gonzales-Rosales F, Walsh D (1997) Intractable nausea and vomiting due to gastrointestinal mucosal metastases relieved by tetrahydrocannabinol. J Pain Sympton Manage 14(5):311–314CrossRef Gonzales-Rosales F, Walsh D (1997) Intractable nausea and vomiting due to gastrointestinal mucosal metastases relieved by tetrahydrocannabinol. J Pain Sympton Manage 14(5):311–314CrossRef
Zurück zum Zitat Hardy J, Daly S, McQuade B et al (2002) A double-blind, randomized parallel group, multinational, multi-centre study comparing ondansetron 24 mg p. o. with placebo and metoclopramide 10 mf tds p. o. in the treatment of opioid induced nausea and emesis in cancer patients. Support Care Cancer 10:331–336CrossRef Hardy J, Daly S, McQuade B et al (2002) A double-blind, randomized parallel group, multinational, multi-centre study comparing ondansetron 24 mg p. o. with placebo and metoclopramide 10 mf tds p. o. in the treatment of opioid induced nausea and emesis in cancer patients. Support Care Cancer 10:331–336CrossRef
Zurück zum Zitat Hestermann U, Backenstrass M, Gekle I et al (2009) Validation of a German version of the Confusion Assessment Method for delirium detection in a sample of acute geriatric patients with a high prevalence of dementia. Psychopathology 42(4):270–276PubMedCrossRef Hestermann U, Backenstrass M, Gekle I et al (2009) Validation of a German version of the Confusion Assessment Method for delirium detection in a sample of acute geriatric patients with a high prevalence of dementia. Psychopathology 42(4):270–276PubMedCrossRef
Zurück zum Zitat McCarthyM HI (1989) Measuring symptoms in terminal cancer: are pain and dyspnea controlled? J R Soc Med 82:264–266CrossRef McCarthyM HI (1989) Measuring symptoms in terminal cancer: are pain and dyspnea controlled? J R Soc Med 82:264–266CrossRef
Zurück zum Zitat Holmes S (1989) Use of a modified symptom distress scale in assessment of the cancer patient. Int J Nurs Stud 26:69–7932PubMedCrossRef Holmes S (1989) Use of a modified symptom distress scale in assessment of the cancer patient. Int J Nurs Stud 26:69–7932PubMedCrossRef
Zurück zum Zitat Inouye B, Bogardus S Jr, Charpentier P et al (1999) A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med 340(9):669–676PubMedCrossRef Inouye B, Bogardus S Jr, Charpentier P et al (1999) A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med 340(9):669–676PubMedCrossRef
Zurück zum Zitat Johnson MJ, McDonagh TA, Harkness A et al (2001) Morphine for the relief of breathlessness in patients with chronic heart failure-a pilot study. Eur J Heart Fail 4:753–756CrossRef Johnson MJ, McDonagh TA, Harkness A et al (2001) Morphine for the relief of breathlessness in patients with chronic heart failure-a pilot study. Eur J Heart Fail 4:753–756CrossRef
Zurück zum Zitat Kovacs C, MacDonald S, Chik C, Bruera E (1995) Hypercalcemia of malignancy in the palliative care patient: a treatment strategy. J Pain Symptom Manage 10:224–232PubMedCrossRef Kovacs C, MacDonald S, Chik C, Bruera E (1995) Hypercalcemia of malignancy in the palliative care patient: a treatment strategy. J Pain Symptom Manage 10:224–232PubMedCrossRef
Zurück zum Zitat Lawlor P, Gagnon B, Mancini I et al (2001) The occurrence, causes and outcome of delirium in advanced cancer patients: a prospective study. Arch Int Med 160:786–794CrossRef Lawlor P, Gagnon B, Mancini I et al (2001) The occurrence, causes and outcome of delirium in advanced cancer patients: a prospective study. Arch Int Med 160:786–794CrossRef
Zurück zum Zitat Leupoldt A, Dahme B (2005) Cortical substrates for the perception of dyspnea. Chest 128(1):345–354CrossRef Leupoldt A, Dahme B (2005) Cortical substrates for the perception of dyspnea. Chest 128(1):345–354CrossRef
Zurück zum Zitat Light RW, Muro JR, Sato RI et al (1989) Effects of oral morphine on breathlessness and exercise tolerance in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 139:126–133PubMedCrossRef Light RW, Muro JR, Sato RI et al (1989) Effects of oral morphine on breathlessness and exercise tolerance in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 139:126–133PubMedCrossRef
Zurück zum Zitat Lowler P (2002) Delirium and dehydration: Some fluid for thought? Support Care Cancer 195:835–839 Lowler P (2002) Delirium and dehydration: Some fluid for thought? Support Care Cancer 195:835–839
Zurück zum Zitat MacKintosh D (2016) Olanzapine in the management of difficult to control nausea and vomiting in a palliative care population: A case series. J Palliat Med 19:87–90PubMedCrossRef MacKintosh D (2016) Olanzapine in the management of difficult to control nausea and vomiting in a palliative care population: A case series. J Palliat Med 19:87–90PubMedCrossRef
Zurück zum Zitat Major P (2001) Use of zeolendroic acid, a novel, highly potent bisphosphonate, for treatment of hypercalcemia of malignancy. Oncologist 7:481–491CrossRef Major P (2001) Use of zeolendroic acid, a novel, highly potent bisphosphonate, for treatment of hypercalcemia of malignancy. Oncologist 7:481–491CrossRef
Zurück zum Zitat Massie M, Holland J, Glass E (1983) Delirium in terminally ill cancer patients. Am J Psychiatry 140:1048–1050PubMedCrossRef Massie M, Holland J, Glass E (1983) Delirium in terminally ill cancer patients. Am J Psychiatry 140:1048–1050PubMedCrossRef
Zurück zum Zitat Mazzocatto C, Buclin T, Rapin CH (1999) The effects of morphine on dyspnea on ventilator function in elderly patients with advanced cancer: a randomized double-blind controlled trial. Annal Oncol 10:1511–1014CrossRef Mazzocatto C, Buclin T, Rapin CH (1999) The effects of morphine on dyspnea on ventilator function in elderly patients with advanced cancer: a randomized double-blind controlled trial. Annal Oncol 10:1511–1014CrossRef
Zurück zum Zitat Menza M, Murray G, Holmes V (1988) Controlled study of extrapyramidal reactions in the management of delirious medically ill patients: Intravenous Haldol versus Haldol plus benzodiazepines. Heart Lung 17:2318–2341 Menza M, Murray G, Holmes V (1988) Controlled study of extrapyramidal reactions in the management of delirious medically ill patients: Intravenous Haldol versus Haldol plus benzodiazepines. Heart Lung 17:2318–2341
Zurück zum Zitat Mercadante S, Avola G, Maddaloni S et al (1996) Octreotide prevents the pathological alterations of bowl obstruction in cancer patients. Support Care Cancer 4:393–394PubMedCrossRef Mercadante S, Avola G, Maddaloni S et al (1996) Octreotide prevents the pathological alterations of bowl obstruction in cancer patients. Support Care Cancer 4:393–394PubMedCrossRef
Zurück zum Zitat Mercadante S, De Conno F, Ripamonti C (1995) Propofol in terminal care. J Pain Symptom Manage 10:639–642PubMedCrossRef Mercadante S, De Conno F, Ripamonti C (1995) Propofol in terminal care. J Pain Symptom Manage 10:639–642PubMedCrossRef
Zurück zum Zitat Mercadante S, Spoldi CA et al (1993) Octreotide in relieving gastrointestinal symptoms due to bowel obstruction. Palliat Med 7:295–299PubMedCrossRef Mercadante S, Spoldi CA et al (1993) Octreotide in relieving gastrointestinal symptoms due to bowel obstruction. Palliat Med 7:295–299PubMedCrossRef
Zurück zum Zitat Morita T, Hyodo I, Yoshimi T et al (2004) Incidence and underlying etiologies of bronchial secretion in terminally ill cancer patients: a multicenter, prospective, observational study. J Pain symptom Manage 27:533–539PubMedCrossRef Morita T, Hyodo I, Yoshimi T et al (2004) Incidence and underlying etiologies of bronchial secretion in terminally ill cancer patients: a multicenter, prospective, observational study. J Pain symptom Manage 27:533–539PubMedCrossRef
Zurück zum Zitat Morita T, Tsunoda J, Inoue S et al (1999) Perception and decision-making on rehydration of terminally ill cancer patients and family members. Am J Hosp Palliat Care 16:509–516PubMedCrossRef Morita T, Tsunoda J, Inoue S et al (1999) Perception and decision-making on rehydration of terminally ill cancer patients and family members. Am J Hosp Palliat Care 16:509–516PubMedCrossRef
Zurück zum Zitat Moyle J (1995) The use of propofol in palliative medicine. J Pain Symptom Manage 10:643–646PubMedCrossRef Moyle J (1995) The use of propofol in palliative medicine. J Pain Symptom Manage 10:643–646PubMedCrossRef
Zurück zum Zitat Muers MF, Round CE (1993) Palliation of symptoms in non-small cell lung cancer: a study by the Yorkshire Regional Cancer Organization Thoracic Group. Thorax 48:339–343PubMedPubMedCentralCrossRef Muers MF, Round CE (1993) Palliation of symptoms in non-small cell lung cancer: a study by the Yorkshire Regional Cancer Organization Thoracic Group. Thorax 48:339–343PubMedPubMedCentralCrossRef
Zurück zum Zitat Nash Smyth E, Conti I, Wooldridge JE et al (2015) Frequency of skeletal-related events and associated health care resource use and costs in US patients with multiple myeloma. J Med Econ 15:1–26 Nash Smyth E, Conti I, Wooldridge JE et al (2015) Frequency of skeletal-related events and associated health care resource use and costs in US patients with multiple myeloma. J Med Econ 15:1–26
Zurück zum Zitat Nellgard P, Bojo L, Cassuto J (1995) Importance of vasoactive intestinal peptide and somatostatin for fluid loss in small bowl obstruction. Scand J Gastroenterol 30:464–469PubMedCrossRef Nellgard P, Bojo L, Cassuto J (1995) Importance of vasoactive intestinal peptide and somatostatin for fluid loss in small bowl obstruction. Scand J Gastroenterol 30:464–469PubMedCrossRef
Zurück zum Zitat Nelville R, Fielding P, Cambria RP, Modlin I (1991) Vascular responsiveness in obstructive gut. Dis Colon Rectum 4:229–235CrossRef Nelville R, Fielding P, Cambria RP, Modlin I (1991) Vascular responsiveness in obstructive gut. Dis Colon Rectum 4:229–235CrossRef
Zurück zum Zitat Oliver D (1985) The use of methotrimeprazine in terminal care. BrJ Clin Pract 39:339–340 Oliver D (1985) The use of methotrimeprazine in terminal care. BrJ Clin Pract 39:339–340
Zurück zum Zitat Passik S, Cooper M (1999) Complicated delirium in cancer patients successfully treated with olanzapine. J Pain Symptom Manage 7:219–223CrossRef Passik S, Cooper M (1999) Complicated delirium in cancer patients successfully treated with olanzapine. J Pain Symptom Manage 7:219–223CrossRef
Zurück zum Zitat Patel S, Lyons A, Hosking D (1993) Drugs used in the treatment of metabolic bone disease. Clinical pharmacology and therapeutic use. Drugs 46:594–617PubMed Patel S, Lyons A, Hosking D (1993) Drugs used in the treatment of metabolic bone disease. Clinical pharmacology and therapeutic use. Drugs 46:594–617PubMed
Zurück zum Zitat Pictus D, Marx MV, Weyman PJ (1988) Chronic intestinal obstruction: value of percutaneous gastrostomy tube placement. Am J Radiol 150:295–297 Pictus D, Marx MV, Weyman PJ (1988) Chronic intestinal obstruction: value of percutaneous gastrostomy tube placement. Am J Radiol 150:295–297
Zurück zum Zitat Ripamonti C, Panzeri C, Groff L et al (2001) The role of somatostatin and octreotide in bowl obstruction: pre-clinical and clinical results. Tumori 87:1–9PubMedCrossRef Ripamonti C, Panzeri C, Groff L et al (2001) The role of somatostatin and octreotide in bowl obstruction: pre-clinical and clinical results. Tumori 87:1–9PubMedCrossRef
Zurück zum Zitat Sarhill N, Walsh D, Nelson K, Davis M (2001) Evaluation and treatment of cancer related fluid deficits: volume depletion or dehydration. Support Care Cancer 9:408–419PubMedCrossRef Sarhill N, Walsh D, Nelson K, Davis M (2001) Evaluation and treatment of cancer related fluid deficits: volume depletion or dehydration. Support Care Cancer 9:408–419PubMedCrossRef
Zurück zum Zitat Schwartz T, Massand P (2001) The role of atypical antipsychotics in the treatment of delirium. Psychosomatics 43:171CrossRef Schwartz T, Massand P (2001) The role of atypical antipsychotics in the treatment of delirium. Psychosomatics 43:171CrossRef
Zurück zum Zitat Sipahimalami A, Sime RM, Massand P (1997) Treatment of delirium with risperdon. In J Geriatric Psychopharmacol 1:24–26 Sipahimalami A, Sime RM, Massand P (1997) Treatment of delirium with risperdon. In J Geriatric Psychopharmacol 1:24–26
Zurück zum Zitat Srivastava M, Brito-Dellan N, Davis MP et al (2003) Olanzapine a s an antiemetic in refractory nausea and vomiting in advanced cancer. J Palliat Med 6:251–255 Srivastava M, Brito-Dellan N, Davis MP et al (2003) Olanzapine a s an antiemetic in refractory nausea and vomiting in advanced cancer. J Palliat Med 6:251–255
Zurück zum Zitat Stark RD, Gambles SA, Lewis JA (1981) Methods to access breathlessness in healthy subjects: a critical evaluation and application to analyze the acute effects of diazepam and promethazin on breathlessness induced by exercise or by exposure to raised levels of carbon dioxide. Clin Sci (Lond) 61:429–439PubMedCrossRef Stark RD, Gambles SA, Lewis JA (1981) Methods to access breathlessness in healthy subjects: a critical evaluation and application to analyze the acute effects of diazepam and promethazin on breathlessness induced by exercise or by exposure to raised levels of carbon dioxide. Clin Sci (Lond) 61:429–439PubMedCrossRef
Zurück zum Zitat Stiefel F, Kornblith A, Holland J, Coyle N, Breitbart W, Weaver S, Portenoy R (1994) Delirium as a contributing factor to ›crescendo‹ pain: Three case reports. J Pain Symptom Manage 9:44–47CrossRef Stiefel F, Kornblith A, Holland J, Coyle N, Breitbart W, Weaver S, Portenoy R (1994) Delirium as a contributing factor to ›crescendo pain: Three case reports. J Pain Symptom Manage 9:44–47CrossRef
Zurück zum Zitat Thomas JR, von Guten CH (2006) Dyspnea. In: Bruera E, Higgins IJ, Ripamonti C, von Guten CH (eds) Textbook of palliative medicine. Oxford University Press, S 655–662 Thomas JR, von Guten CH (2006) Dyspnea. In: Bruera E, Higgins IJ, Ripamonti C, von Guten CH (eds) Textbook of palliative medicine. Oxford University Press, S 655–662
Zurück zum Zitat Twycross R, Back I (1998) Nausea and vomiting in advanced cancer. Eur J Palliat Care 5:39–45 Twycross R, Back I (1998) Nausea and vomiting in advanced cancer. Eur J Palliat Care 5:39–45
Zurück zum Zitat Ventafridda V, Ripamonti C, Caraceni A et al (1990a) The management of inoperable gastrointestinal obstruction in terminal cancer patients. Tumori 76:389–393PubMedCrossRef Ventafridda V, Ripamonti C, Caraceni A et al (1990a) The management of inoperable gastrointestinal obstruction in terminal cancer patients. Tumori 76:389–393PubMedCrossRef
Zurück zum Zitat Ventafridda V, Ripamonti C, DeConno F (1990b) Symptom prevalence and control during cancer patients´ last days of life. J Palliat Care 6:7–11PubMedCrossRef Ventafridda V, Ripamonti C, DeConno F (1990b) Symptom prevalence and control during cancer patients´ last days of life. J Palliat Care 6:7–11PubMedCrossRef
Zurück zum Zitat Williams SG, Wright DJ, Marshall P et al (2002) Safety and potential benefits of low dose diamorphine during exercise in patients with chronic heart failure. Heart 88:1085–1086 Williams SG, Wright DJ, Marshall P et al (2002) Safety and potential benefits of low dose diamorphine during exercise in patients with chronic heart failure. Heart 88:1085–1086
Zurück zum Zitat Woodcock AA, Gross ER, Geddes DM (1981) Drug treatment of breathlessness: contrasting effects of diazepam and promethazine in pink puffers. Br Med J (Clin Re Ed) 281:343–346CrossRef Woodcock AA, Gross ER, Geddes DM (1981) Drug treatment of breathlessness: contrasting effects of diazepam and promethazine in pink puffers. Br Med J (Clin Re Ed) 281:343–346CrossRef
Zurück zum Zitat Zebraski SE, Kochenash SM, Raffa RB (2000) Lung opioid receptors: pharmacology and possible target for nebulized morphine in dyspnea. Life Sci 66:2221–2231PubMedCrossRef Zebraski SE, Kochenash SM, Raffa RB (2000) Lung opioid receptors: pharmacology and possible target for nebulized morphine in dyspnea. Life Sci 66:2221–2231PubMedCrossRef
Metadaten
Titel
Symptomkontrolle
verfasst von
Herbert Watzke
Copyright-Jahr
2023
Verlag
Springer Berlin Heidelberg
DOI
https://doi.org/10.1007/978-3-662-65768-3_5

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.